Schonfeld Strategic Advisors »

Aslan Pharmaceuticals shares owned by Schonfeld Strategic Advisors

Quarter-by-quarter ownership of Aslan Pharmaceuticals (ASLN) shares owned by Schonfeld Strategic Advisors from 13F filings

Historical chart of Schonfeld Strategic Advisors investment in Aslan Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Aslan Pharmaceuticals held by Schonfeld Strategic Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aslan Pharmaceuticals by Schonfeld Strategic Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $15k 28k 0.52
2023-09-30 $172k 92k 1.88
2023-06-30 $199k 54k 3.65

More positions owned by Schonfeld Strategic Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon (AMZN)
FedEx Corporation (FDX)
Microsoft Corporation (MSFT)
Ishares Msci Brazil Etf Call Option (EWZ)
Ishares Tr U.s. Real Es Etf (IYR)
Mastercard Incorporated Cl A (MA)
NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Verizon Communications (VZ)
Spdr Ser Tr S&p Biotech (XBI)
Micron Technology (MU)
Johnson Ctls Intl SHS (JCI)

View all positions for Schonfeld Strategic Advisors

Top funds holding Aslan Pharmaceuticals

BVF
UBS Group
Citadel Advisors
Shay Capital
Landscape Capital Management
Millennium Management
FNY Investment Advisers
Waterfront Wealth
Ikarian Capital
Schonfeld Strategic Advisors
Jane Street
Onyx Bridge Wealth Group
Capital Analysts
Rhumbline Advisers
Cutler

View all funds holding Aslan Pharmaceuticals